• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Rabbit anti-Human OCC1 Polyclonal Antibody

The antibody against OCC1 was raised in rabbit using the Synthetic peptide of Human C12orf75 as the immunogen. This antibody exists as a non-conjugated isotype IgG, Antigen affinity purified. This antibody has been validated on ELISA, IHC.

ADC-26246A

The antibody against OCC1 was raised in rabbit using the Synthetic peptide of Human C12orf75 as the immunogen. This antibody exists as a non-conjugated isotype IgG, Antigen affinity purified. This antibody has been validated on ELISA, IHC.

$299.00

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ADC-26246A ClonalityPolyclonal
Host SpeciesRabbitTarget NameOCC1
FormLiquidSpecies ReactivityHuman
IsotypeIgGStorage Buffer0.05% NaN3, 40% Glycerol., pH7.4 PBS
Purification MethodAntigen affinity purifiedConjugateNon-conjugated
ApplicationELISA, IHCStorageUpon receipt

Immunogen Information


Immunogen DescriptionSynthetic peptide of Human C12orf75Target SpeciesHuman
Immunogen SequenceComplete sequences for the immunogen, target protein, and peptides are available upon request.Uniprot IDQ8TAD7
Background Information
  • Uniprot Id

    Q8TAD7

  • Target Species

    Human

  • Target Name

    OCC1

  • Target Full Name

    Overexpressed in colon carcinoma 1 protein

  • Target Synonyms

    Adipogenesis down regulated 3; AGD3; C12orf75; Chromosome 12 open reading frame 75; Hypothetical protein LOC387882; MGC148100; MGC149157; OCC 1; OCC-1; OCC1; OCC1_HUMAN; Overexpressed in colon carcinoma 1; Overexpressed in colon carcinoma 1 protein; Putative overexpressed in colon carcinoma 1 protein

Inquire Rabbit anti-Human OCC1 Polyclonal Antibody Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification